| At least 3.3 million Americans currently
| |
| | disease and stroke to begin with, any
|
| take medications to ease the symptoms of
| |
| | increase in risk caused by these drugs
|
| Attention Deficit Disorder. The majority
| |
| | could affect a large number of people.One
|
| of these medications are
| |
| | committee member stated that not
|
| amphetamine-based stimulants.The doctors
| |
| | disclosing the risks associated with
|
| prescribe these drugs, but that does not
| |
| | taking these drugs is unethical. Because
|
| mean they are necessarily safe, says the
| |
| | of the gravity of the side effects,
|
| Federal Drug Administration which is
| |
| | namely sudden death, physicians need to
|
| currently looking at placing strong
| |
| | be clearly aware of the serious side
|
| warnings on stimulant ADD medications
| |
| | effects before prescribing these drugs to
|
| like Ritalin, Adderall and Concerta.An
| |
| | their patients. The panel, while
|
| FDA advisory panel voted in February to
| |
| | expressing concern about the over
|
| recommend that all stimulant ADHD drugs
| |
| | prescribing of ADHD medications, stated
|
| carry a "black box" warning - the
| |
| | that they want physicians to pause before
|
| strongest possible safety warning - to
| |
| | writing prescriptions for stimulant
|
| indicate that the drugs may increase the
| |
| | medications. The FDA advisory committee
|
| risk of heart attacks, strokes and sudden
| |
| | also unanimously recommended that the FDA
|
| death.Black box warnings are intended to
| |
| | include medication guides with all
|
| alert physicians and patients that a drug
| |
| | stimulant ADHD drugs warning about the
|
| may carry significant risks. The FDA
| |
| | risks.FDA is not required to follow
|
| advisory panel ruled on this black box
| |
| | recommendations given by the advisory
|
| warning after reviewing data concerning
| |
| | committee, though the FDA usually does
|
| death and other negative heart problems
| |
| | follow recommendations. The FDA awaits
|
| associated with stimulant drug medication
| |
| | advice from its pediatric panel in March
|
| use. Although data varies between
| |
| | before reaching a decision. The FDA plans
|
| reporting agencies, 25 to 51 deaths have
| |
| | to refer the issue to another advisory
|
| been attributed to ADHD medication use.
| |
| | panel that deals with psychological
|
| Experts estimate that less than 10
| |
| | problems in children. Additionally, the
|
| percent of serious drug reactions are
| |
| | FDA is planning a new study of ADHD drugs
|
| reported to the FDA, so the deaths and
| |
| | that will take approximately 18 months to
|
| serious adverse effects are undoubtedly
| |
| | complete. Some are adamant that the FDA
|
| much higher.Of the reported deaths
| |
| | should not wait for the results of this
|
| studied by the advisory panel, 19 were
| |
| | study. The FDA has been criticized in the
|
| children. Other reports described 54
| |
| | past for being slow to respond to
|
| cases of high blood pressure, chest pain,
| |
| | evidence of health risks associated with
|
| heart attacks, strokes, irregular heart
| |
| | such things as drugs, including
|
| beats and fainting. The number of
| |
| | painkillers and antidepressants.At least
|
| arrhythmia has been surprising. It is
| |
| | two million children and one million
|
| believed to be the pathway for the
| |
| | adults take prescription ADHD medication
|
| sudden, unexplained deaths. And because
| |
| | every month.
|
| adults have a higher risk of heart
| |
| |
|
